Filter
561
Filtered Results: 561
Text search:
interpretation
primer
Featured
Recommendations
49
New Publications
105
Language
Document type
No document type
237
Guidelines
150
Studies & Reports
70
Manuals
57
Strategic & Response Plan
27
Training Material
10
Fact sheets
8
Brochures
1
Resource Platforms
1
Countries / Regions
Latin America and the Carribbean
69
Argentina
27
Colombia
26
Paraguay
22
Global
21
Venezuela
16
Ecuador
14
Bolivia
12
India
9
Peru
9
El Salvador
7
Chile
6
Africa
5
Spain
5
Honduras
4
Guatemala
3
Mexico
3
Nicaragua
3
Western and Central Europe
3
Uruguay
3
Philippines
2
Kenya
2
Liberia
1
Senegal
1
USA
1
Ethiopia
1
Cameroon
1
Zimbabwe
1
Nepal
1
Thailand
1
Indonesia
1
Dominican Republic
1
Brazil
1
Cuba
1
Myanmar / Burma
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
Countries
180
Clinical Guidelines
69
Women & Child Health
34
Public Health
25
Pharmacy & Technologies
23
Key Resources
19
Capacity Building
4
Toolboxes
COVID-19
76
TB
69
Mental Health
57
HIV
30
Rapid Response
29
Zika
26
Planetary Health
26
NTDs
25
Disability
24
AMR
21
Caregiver
16
Global Health Education
8
Pharmacy
8
Natural Hazards
7
Conflict
5
Social Ethics
5
Ebola
4
Cholera
4
Refugee
4
NCDs
4
Polio
3
Specific Hazards
2
Health Financing Toolbox
2
2nd edition .
This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenza viruses or other non-influenza pathogens or biological substances that may be contained in clinical ...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
Polymerase Chain Reaction (PCR) has significantly helped in early diagnosis and commencement of specific interventions for diseases control. It also plays a critical role in understanding the disease epidemiology and unraveling the transmission dynamics of the disease. This manual intends to p...
The National Guidelines for HIV-1 Viral Load Laboratory Testing support plans to scale up viral load (VL) testing to reach the 90-90-90 targets in India. This phased scale-up includes the setup of 70 additional VL testing laboratories nationally. These guidelines include laboratory design considerat...
Building laboratory testing capacity
Manual for use in primary care
Manual for use in primary care.
This manual explains the theoretical basis and evidence for the effectiveness of brief interventions and assists primary health care workers in conducting a simple brief intervention for clients whose substance use is putting them at risk.
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
Improvements in water sanitation and hygiene (WASH) and wastewater management in all sectors are critical elements of preventing infections and reducing the spread of antimicrobial resistance (AMR) as identified in the Global Action Plan to combat AMR. Yet, at present, WASH and wastewater management...
Investing in and building longer-term health emergency preparedness during the COVID-19 pandemic
recommended
Interim Guidance
This document is to help Member States build on actions taken during the COVID-19 pandemic to improve national medium- to long-term preparedness for future threats. It maps COVID-19 preparedness and response actions to the building of sustainable International Health Regulations (2...
A total of 18 laboratories from 13 countries participated in the four rounds of EQA: 10 laboratories from eight African endemic countries, four of which participated in all four rounds and three in three rounds. The overall results showed that the median performance of these laboratories improved ov...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
